Loading...
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]
INTRODUCTION: Experimental and clinical data show that the oral bisphosphonate clodronate (Bonefos(®)) can inhibit tumor-induced osteoclastic bone resorption. This randomized, double-blind, placebo-controlled, multicenter trial was designed to determine if the addition of oral clodronate to standard...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BioMed Central
2006
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1557723/ https://ncbi.nlm.nih.gov/pubmed/16542503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr1384 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|